...
首页> 外文期刊>Indian Journal of Ophthalmology >A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation
【24h】

A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation

机译:Golimumab和Ahmed瓣膜植入术成功治疗特发性坏死性巩膜炎合并继发性青光眼

获取原文
           

摘要

A 52-year-old woman presented with idiopathic active scleritis not responding to oral cyclophosphamide, azathioprine, and oral steroid. Her intraocular pressure in the left eye was 45 mm of Hg in spite of using combination of brinzolamide 1% and brimonidine 0.2% (thrice a day), timolol maleate 0.5% (twice a day) eye drops in both eyes and oral acetazolamide. She was administered subcutaneous golimumab 50 mg injection every 4 weeks along with oral methotrexate 15 mg/week. The scleral inflammation responded and she underwent Ahmed glaucoma valve implantation after two months of initiation of golimumab therapy. After one week of surgery her IOP in left eye was the reduced to 8 mm of Hg. The index case showed that Golimumab can be a useful drug in the management of necrotizing scleritis refractory to the conventional therapy.
机译:一名52岁的女性表现为特发性活动性巩膜炎,对口服环磷酰胺,硫唑嘌呤和口服类固醇无反应。尽管联合使用了1%的苯二甲酰胺和0.2%的溴莫尼定(每天三次),左眼的眼内压为45毫米汞柱,但双眼和口服乙酰唑胺的滴眼液仍是。每4周给她皮下注射golimumab 50 mg注射液,并口服甲氨蝶呤15 mg /周。戈利木单抗治疗开始两个月后,巩膜发炎,她接受了艾哈迈德青光眼瓣膜植入术。手术一周后,她的左眼眼压降低至8毫米汞柱。该指数病例表明,戈利木单抗可以作为常规疗法难治的坏死性巩膜炎的有用药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号